curaleaf

Pennsylvania approves four firms to grow cannabis for research

Four more medical marijuana companies – including multistate operator Curaleaf – have been approved by Pennsylvania regulators to grow MMJ that state universities can use for research. Curaleaf, which is based in Massachusetts but seeking a license to sell medical marijuana in Pennsylvania, is contracted to grow MMJ for the Perelman School of Medicine at the […]

Read More

Chart: New York’s medical marijuana program grows, but future business opportunity hinges on adult-use legalization

While New York’s medical cannabis patient registry increased by more than 23,000 in 2019, growth has slowed significantly because of various market factors leading to a low consumer participation rate. Less than 1% of New York residents have signed on as medical marijuana patients, due in part to restrictions on cannabis product forms and limited […]

Read More

Large US cannabis companies look to debt funding versus equity and sale-leaseback deals

Big marijuana companies in the United States increasingly are turning to debt as a funding tool, spurred by falling cannabis stock prices and terms that are more attractive than those for real estate sale-leaseback deals. Multistate operators Curaleaf, headquartered in Massachusetts, and Cresco Labs, based in Chicago, have led the way by announcing debt raises […]

Read More

New cannabis investing opportunities: Interview with Jeff Schultz, Navy Capital

Jeff Schultz is a partner and general counsel at New York-based investment firm Navy Capital. The company has approximately $200 million invested in the cannabis industry across about 40 different companies. About 90% of those are in the United States, with more than half being plant-touching businesses. The rest of the $200 million is split […]

Read More

Multistate marijuana firm Curaleaf raises $275 million in debt

Curaleaf, a Massachusetts-based multistate marijuana operator, secured $275 million in debt from a syndicate of lenders. It’s believed to be the largest amount of debt ever raised in the U.S. marijuana industry. The company plans to use the money to refinance existing debt, fund previously announced acquisition expenses and capital expenditures and for general corporate […]

Read More

Week in Review: USDA issues hemp rules, Mexican recreational cannabis vote delayed, spring rollout for Michigan’s rec market & more

The U.S. Department of Agriculture (USDA) unveils its hotly anticipated hemp regulations, Mexico’s bid to legalize recreational marijuana is delayed, sales of adult-use MJ in Michigan won’t begin until March or April at the earliest – and more of the week’s top cannabis business news. USDA rolls out hemp rules The USDA released 160 pages of […]

Read More

Curaleaf amends Cura Partners marijuana deal; antitrust hurdle cleared

Curaleaf, a Massachusetts-based, multistate cannabis operator, is amending the terms of its pending acquisition of Cura Partners because of changing market conditions. Curaleaf, which initially announced the proposed deal in May for an estimated price of almost $1 billion, will now issue 55 million of its shares instead of the original 95.6 million shares in the […]

Read More

Antitrust cloud lifting on cannabis M&A deals, but will some be renegotiated – or even abandoned?

The antitrust cloud hanging over several large mergers and acquisitions in the U.S. marijuana industry appears to be lifting, but its effects continue to linger and could remain a factor if the deals ultimately are renegotiated or even scrapped in a difficult funding environment. In recent weeks, a number of marijuana companies have announced that […]

Read More

Bloom Farms, Cura Partners settle marijuana lawsuit

California-based cannabis company Bloom Farms settled a defamation lawsuit filed by Oregon’s Cura Partners for an undisclosed sum. Neither company would disclose details of the settlement of the case filed in January in Alameda County Superior Court in California, according to multiple news reports. Cura claimed in the suit that Bloom, an industry rival, had […]

Read More

Florida’s medical cannabis industry has only one truly dominant player

Florida’s medical marijuana market is often described by industry watchers as an oligopoly – dominated by a few vertically integrated operators. But it isn’t. The reality is that the roughly half-billion-dollar market is dominated by one player – Florida-based Trulieve, which is capturing nearly 50% of all sales. No other company comes close. Experts say […]

Read More